Passage Bio Stock Price Prediction
As of 13th of June 2025 the rsi of Passage Bio's share price is below 20 indicating that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.
The successful prediction of Passage Bio's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Passage Bio and does not consider all of the tangible or intangible factors available from Passage Bio's fundamental data. We analyze noise-free headlines and recent hype associated with Passage Bio, which may create opportunities for some arbitrage if properly timed.
Momentum 0
Sell Peaked
Oversold | Overbought |
Using Passage Bio hype-based prediction, you can estimate the value of Passage Bio from the perspective of Passage Bio response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Passage Bio to buy its stock at a price that has no basis in reality. In that case, they are not buying Passage because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Passage Bio after-hype prediction price | USD 0.39 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. Symbol | PASG |
Name | Passage Bio |
Type | Stock |
Country | United States |
Exchange | NASDAQ |
Hype Analysis is not found for Passage Bio at this timeWe are unable to locate Passage Bio hype analysis at this time. If you believe the equity you are trying to look up is valid, please let us know, and we will check it out.Hype Analysis
Prediction analysis is currently not available
Other Suggestions
PA | PanAmSat Holding P | CompanyDelisted |
PAA | Plains All American | Company |
PAI | Platinum Asia Investments | Fund |
PAB | PGIM ETF Trust | ETF |
PAY | PAY | Cryptocurrency |
PAUSD | Palladium | Commodity |
Thematic Opportunities
Explore Investment Opportunities
Did you try this?
Run Positions Ratings Now
Positions RatingsDetermine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |
All Next | Launch Module |
Passage Bio Additional Predictive Modules
Most predictive techniques to examine Passage price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Passage using various technical indicators. When you analyze Passage charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
About Passage Bio Predictive Indicators
The successful prediction of Passage Bio stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Passage Bio, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Passage Bio based on analysis of Passage Bio hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Passage Bio's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Passage Bio's related companies.
Story Coverage note for Passage Bio
The number of cover stories for Passage Bio depends on current market conditions and Passage Bio's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Passage Bio is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Passage Bio's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Passage Bio Short Properties
Passage Bio's future price predictability will typically decrease when Passage Bio's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Passage Bio often depends not only on the future outlook of the potential Passage Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Passage Bio's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding | 60.4 M | |
Cash And Short Term Investments | 76.8 M |
Complementary Tools for Passage Stock analysis
When running Passage Bio's price analysis, check to measure Passage Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Passage Bio is operating at the current time. Most of Passage Bio's value examination focuses on studying past and present price action to predict the probability of Passage Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Passage Bio's price. Additionally, you may evaluate how the addition of Passage Bio to your portfolios can decrease your overall portfolio volatility.
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |